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Abstract--Programmed cell death, or apoptosis, may play an important role in the regulation 
of hematopoiesis. The tumor suppressor protein p53 has been identified as a key regulator of 
apoptosis in both normal and malignant hematopoietic cells. Modulation of p53 function is of 
interest, therefore, both in understanding the control of apoptosis and as a potential therapeutic 
intervention. In this study we describe the effect on murine erythroleukemia cells, transfected 
with a temperature-sensitive mutant p53, of exposure to the differentiating agent dimethyl- 
sulfoxide (DMSO). Rather than terminally differentiating, these cells are induced to undergo 
apoptosis. Interestingly, exposure to DMSO leads to an alteration of the protein conformation 
of the p53 mutant to one recognized by a wild-type specific monoclonal antibody. This is 
accompanied by a translocation of the p53 protein from the cytoplasm to the nucleus. These 
results suggest that the activity of some mutant p53 proteins can be functionally modified by 
exogenous compounds. 
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Introduction 
P R O G R A M M E D  C E L L  D E A T t t ,  o r  apoptosis, is n o w  
thought to be an important regulatory process in 
normal hematopoiesis and in tumor suppression. 
Hematopoietic progenitor cells are dependent on 
cytokines not only for proliferation but also to pre- 
vent apoptosis [1].  The genetic regulation of 
apoptosis is poorly understood. Yonish-Roach et al. 
have shown that re-introduction of wild-type p53 
expression induces apoptosis in the murine M1 
myeloid leukemic cell line [2]. This effect is inhibited 
by exposure of M1 cells to the growth factor 
interleukin-6 and enhanced by treatment with trans- 
forming growth factor beta [3]. Wild-type p53 
expression is also necessary for some forms of 
induced apoptosis in normal hematopoietic cells [4]. 
In the murine erythroleukemia (MEL) cell line 
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Rous sarcoma virus long terminal repeat. 
Correspondence to: Michael F. Clarke, Division of 
Hematology/Oncology, University of Michigan Medical 
Center, 1150 West Medical Center Drive, C570 MSRB II, 
Ann Arbor, MI 48109-0668, U.S.A. 
617 
DP16-1, re-introduction of a temperature-sensitive 
p53 mutant (p53 yaH35) allows the effect of wild-type 
p53 expression to be studied by temperature down- 
shift [5]. The p53 tS mutant behaves as a mutant p53 
in cells cultured at 37°C; at 32.5°C the protein under- 
goes a conformational change to that recognized by 
wild-type specific antibodies and is translocated from 
the cytoplasm to the nucleus in rat embryo fibroblast 
cells [6, 7]. Transfer of DP16-1 MEL cells transfected 
with a p53 tS expression vector to 32.5°C results in G1 
cell cycle arrest and subsequent apoptotic cell death 
[5]. This is accompanied by movement of p53 into 
the cell nucleus. 
Murine erythroleukemia cells can be induced to 
differentiate into mature red cells by treatment with 
a number of chemical agents, including dimethyl- 
sulfoxide (DMSO). DP16-1 cells exposed to 1.6% 
DMSO will differentiate, as measured by benzidine 
staining for hemoglobin content, over a period of 4- 
5 days. When DP16-1 cells transfected with p53 ts are 
treated with DMSO at 37°C, apoptosis, rather than 
differentiation, ensues in the majority of cells. Anti- 
body studies demonstrate that this is correlated with a 
conformational change in the p53 protein and nuclear 
localization. This finding suggests that p53 activity 
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TABLE l .  VIABILITY AND DIFFERENTIATION OF DP16-1  




Benzidine + Benzidine + 
0 h 97% <5% 96% <5% 
24 h 95% <5% 71% <5% 
48 h 91% 12% 41% <5% 
72 h 89% 33% 29% <5% 
96 h 86% 64% 10% 8.5% 
120 h 85% 81% 4.5% ND 
MEL cells were cultured in 1.6% DMSO for the indi- 
cated time periods (h = hours) at 37°C and viability deter- 
mined by trypan blue exclusion and differentiation by 
benzidine staining for hemoglobin content. Each per- 
centage given is the mean of three separate experiments; 
each data point was obtained from counting a minimum 
of 100 cells. The 120 h benzidine stain of the clone nine ceils 
was not done (ND) secondary to an insufficient number of 
intact cells. 
a 13 
can be influenced th rough  exposure to differentiating 
agents such as D M S O .  C o m p o u n d s  influencing the 
cellular localization and function of  mutant  p53 are 
of  potent ial  therapeut ic  value. 
Materials  and Methods  
Stable p53 tS transfectants 
p53tSneo contains the coding sequence of the neomycin 
resistance gene under the regulation of an SV40 promoter 
and the coding sequences of p53 val-135 linked to an RSV 
LTR promoter. This plasmid was derived from plasmid 
pLTRp53cG (a gift of M. Oren) as previously described 
[5]. p53tSneo was linearized with BamHI and transfected 
into DP16-1 MEL cells (a gift of S. Benchimol) by elec- 
troporation, as previously described [5]. Transfected cells 
were selected in DMEM media containing 1 mg of geneticin 
(G418,GIBCO) per ml. Single cell clones were isolated by 
limiting dilution in 96-well microtiter plates. To induce 
differentiation, logarithmically growing cells were grown 
in medium containing 1.6% DMSO (Sigma) for a total of 
5 days. Media were changed every other day. Benzidine 
staining was performed as previously described [5]. Cell 
viability was measured by trypan blue exclusion. 
p53 immunoprecipitation 
Clone 9 cells were cultured at 37°C, with and without 
1.6% DMSO, for 24 h and then labeled for 3 h with 0.2 mCi 
of [3sS] methionine. Immunoprecipitations were performed 
as previously described [5], Lysates (2 x 106 cells) were 
precipitated with PAb421, a pan-specific monoclonal anti- 
body against p53, PAb246, a routine p53-specific mono- 
clonal antibody that recognizes wild-type p53, and PAb240, 
a p53-specific monoclonal antibody that recognizes an epi- 
tope present on mutant forms of p53 [7]. Untransfected 
parental DP16-1 MEL cells were immunoprecipitated with 
the same antibodies as a negative control. Immune com- 
plexes were collected with protein A agarose beads 
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FIG. 1. DNA fragmentation in p53-induced apoptosis. 
Genomic DNA (3 gg) was extracted [51 from clone 9 cells 
(lane a) and DP16-1 cells (lane b) after incubation for 24 h 
in DMEM media containing 1.6% DMSO. DNA was then 
analyzed by electrophoresis through a 1.5% agarose gel. 
An apoptotic ladder is clearly seen in DNA derived from 
the clone 9 cells. 
(Bethesda Research Laboratories), washed three times in 
lysis buffer, electrophoresed through 10% polyacrylamide 
in the presence of SDS and dried gels used for autoradio- 
graphy. 
Immunohistochemistry 
Clone 9 cells were cultured at 37°C in the presence and 
absence of 1.6% DMSO for 24 h. Untransfected DP16-1 
cells were grown at 37°C as a negative control. 2.5 x 105 
cells were then suspended in FACS buffer [5] and pelleted 
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FIG. 2. Immunohistochemistry showing the cellular local- 
ization of p53 at 37°C in the presence and absence of 1.6% 
DMSO. The lower panel shows the untransfected parental 
cell line DP16-1 stained with PAb421; DP16-1 has no 
detectable expression of endogenous p53. The middle 
panel shows p53t~neo transfected DP16-1 cells (clone 9) 
grown at 37°C without added DMSO and the expected 
cytoplasmic staining (white arrows) is seen. The upper 
panel demonstrates the nuclear staining (white arrows) 
seen in clone 9 cells cultured in 1.6% DMSO for 24 h prior 
to p53 staining. 
on a microscope slide using a cytospin centrifuge 
(Shandon). Cells were fixed with methanol for 1 h at 4°C 
and then washed in PBS. Forty microliters of PAb421 were 
added to each slide for 1 h at room temperature. Following 
a PBS wash, 25 ~tl of GAM-FITC (Tago) were added 
for 1 h at room temperature. Staining was visualized by 
fluorescence microscopy. 
Results 
Several DP16-1 p53 t+ transfected subclones were 
studied by culture at 37°C in the presence of 1.6% 
DMSO. These clones have previously been shown to 
express p53-specific RNA and protein [5]. In contrast 
to the parental cell line DP16-1, which maintains 
viability and differentiates over a 4-5 day period 
(Table 1), the p53 t+ transfectants lose viability, with 
most cells dying prior to developing positive ben- 
zidine staining. Data for a representative clone, C9, 
are shown in Table 1. Apoptosis is characterized by 
activation of an endogenous endonuclease leading to 
fragmentation of genomic DNA secondary to inter- 
nucleosomal cleavage. This pattern is clearly seen in 
C9 cells exposed to 1.6% DMSO for 24 h, while 
only high molecular weight DNA is extracted from 
similarly treated DP16-1 cells (Fig. 1). This is con- 
sistent with an induction of apoptosis by p53 in the 
DMSO-treated p53 t~ transfectants. 
Immunohistochemistry was then performed on C9 
cells growing at 37°C with and without 1.6% DMSO 
for 24 h. p53 staining clearly showed a nuclear pattern 
in DMSO-treated cells, as compared with the 
expected cytoplasmic staining of untreated cells (Fig. 
2). Parental DP16-1 cells showed no p53-specific 
staining. 
To examine whether a conformational change in 
the p53 t~ protein occurs with nuclear translocation, 
we performed p53 immunoprecipitations on C9 cells 
growing in 1.6% DMSO. The monoclonal antibody 
PAb246 is specific for an epitope of the wild-type 
murine p53 conformation. At 37°C less than 5% of 
the p53 '~ protein can be precipitated with PAb246, 
while a significantly higher proportion can be pre- 
cipitated at 32.5°C [7, 8]. The mutant-specific mono- 
clonal antibody PAb240 can detect the majority of 
p53 protein at 37°C; these results are confirmed in 
C9 cells cultured at 37°C in the absence of DMSO 
(Fig. 3). Figure 4 shows that in DMSO-treated C9 
cells at 37°C a significant proportion of the total p53 
protein (as detected by the pan-specific antibody 
PAb421) is recognized by PAb246. In contrast, much 
less protein is precipitated with the mutant p53- 
specific monoclonal antibody PAb240. This is con- 
sistent with a shift to a wild-type protein con- 
formation secondary to DMSO exposure and would 
explain the observed nuclear localization of the p53 
protein. 
Discussion 
The subcellular location of p53 is thought to modu- 
late its actions. Mutant forms of the protein are often 
associated with the heat shock protein hsp 70 and 
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FlG. 3. Conformational analysis of p53 tS protein in clone 
9 cells, p53 was immunoprecipitated using conformation 
specific monoclonal antibodies [7] from labeled parental 
DP16-1 (lanes a, c, e) and clone 9 cells (lanes b, d, f) 
cultured at 37°C without DMSO. A majority of the total 
protein (precipitated with the non-specific antibody 
PAb 421) is recognized by the mutant specific antibody 
PAb 240. No precipitable protein is seen in the untrans- 
fected DP16-1 MEL cells with any of the antibodies used. 
localized in the cytoplasm [9]. The temperature-sen- 
sitive mutant used in these experiments is localized 
in the cytoplasm when cells are grown at 37°C (when 
the protein is in a mutant conformation) and trans- 
locates into the nucleus when cells are grown at 
32.5°C (when the p53 is in a wild-type conformation). 
In p53 tS MEL cells nuclear localization of the p53 
protein is associated with G1 growth arrest and 
apoptosis [5]. Interleukin-6 treatment of M1 myeloid 
leukemia cells inhibits p53-induced apoptosis without 
affecting nuclear translocation [10]. The factors regu- 
lating transport of p53 intracellularly are not known. 
Evidence has been presented that a short-lived pro- 
tein is responsible for anchoring mutant p53 in the 
cytoplasmic compartment [11]. Downregulation of 
this putative protein might, therefore, allow entry of 
p53 into the nucleus. Alternatively, a change in p53 
protein conformation may allow release from a cyto- 
plasmic anchoring protein. 
In this study exposure of p53 t~ transfected MEL 
cells to DMSO resulted in nuclear translocation of 
the p53 protein. Immunoprecipitation data support 
the concept that a change in protein conformation 
allows entry into the nucleus. The p53 is functionally 
active and fundamentally alters the phenotype of 
cells cultured in DMSO. During normal myeloid 
differentiation p53 protein levels increase [12]. Entry 
of p53 into the nuclear compartment during induced 
differentiation may be important in its role as a tumor 
suppressor protein; apoptosis would be induced in 
those cells with extensive DNA damage or genetic 
alterations while differentiation would be promoted 
in less mutated cells. This idea is supported by the 
finding that wild-type p53 can promote differenti- 
ation in a chronic myelogenous leukemia cell line 
[13], as well as in murine erythroleukemia cells ([8], 
Ryan J. & Clarke M. F., unpublished observations). 
An understanding of the factors regulating the sub- 
cellular localization of p53 will be an important step 
in the development of targeted cancer therapeutics. 
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FIG. 4. Conformational analysis of p53 ts protein in clone 9 
cells, p53 was immunoprecipitated using conformation- 
specific monoclonal antibodies [7] from labeled clone 9 
cells exposed to 1.6% DMSO for 24 h. A significant pro- 
portion of the total p53 protein (precipitated with PAb421) 
is recognized by the wild-type specific antibody PAb246 
while a smaller percentage is recognized by the mutant 
conformation specific antibody PAb240. 
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